Annex 4 - WHO
153 Annex 4 Recommendations to assure the quality, safety and efficacy of influenza vaccines (human, live attenuated) for intranasal administration
Download Annex 4 - WHO
Information
Domain:
Source:
Link to this page:
Documents from same domain
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Related documents
Biosimilars, Oxidative Damage, and Unwanted …
www.bioprocessintl.com28 BioProcess International 11(6)s Ju n e 2013 Supplement B i o s i m i l a r s Technical Biosimilars, Oxidative Damage, and Unwanted Immunogenicity A Review by Edward T. Maggio C oncerns about the economic viability of biosimilars center
Biosimilars in the EU
www.ema.europa.euInformation guide for healthcare professionals Biosimilars in the EU Prepared jointly by the European Medicines Agency and the European Commission
FIRST DRAFT Guideline on clinical evaluation of …
www.ema.europa.euGuideline on clinical evaluation of vaccines EMEA/CHMP/VWP/164653/05 Rev. 1 Page 6/21 165 4. Immunogenicity 166 4.1. Characterisation of the immune response
New Zealand Data Sheet - Medsafe
www.medsafe.govt.nzNew Zealand Data Sheet Page 1 of 7 DUKORAL®. Vibrio cholerae. and enterotoxigenic . Escherichia coli. vaccine . Name of the Medicine . Vaccine containing heat inactivated Vibrio cholerae O1 Inaba classic strain, formalin inactivated Vibrio cholerae O1 Inaba El Tor strain, heat inactivated Vibrio cholerae O1 Ogawa classic strain, formalin …
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.merck.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use RECOMBIVAX HB safely and effectively. See full prescribing
Guidelines on Clinical Evaluation of Vaccines: …
www.who.int1 2 3 WHO/DRAFT/27 January 2016 4 ENGLISH ONLY 5 6 7 Guidelines on Clinical Evaluation of Vaccines: Regulatory Expectations 8 Proposed revision of WHO TRS 924, Annex 1 9 10 NOTE: 11 12 This document has been prepared for the purpose of inviting comments and suggestions on the proposals 13 contained therein, which will …
Morbidity and Mortality Weekly Report
www.cdc.govMorbidity and Mortality Weekly Report Recommendations and Reports June 22, 2007 / Vol. 56 / No. RR-4 INSIDE: Continuing Education Examination depardepardepartment of health and human servicesvicesvices
Related search queries
Biosimilars, Oxidative Damage, and Unwanted, Biosimilars, Oxidative Damage, and Unwanted Immunogenicity, Biosimilars in the EU, Immunogenicity, New Zealand Data Sheet, RECOMBIVAX HB, Clinical Evaluation of Vaccines:, Clinical Evaluation of Vaccines: Regulatory Expectations, Morbidity and Mortality Weekly Report